Tenecteplase Is Reasonable Alternative to Alteplase for Ischemic Stroke
MONDAY, March 24, 2025 -- For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes, according to a study published online March 12 in JAMA Network Open.
Justin F. Rousseau, M.D., from the University of Texas Southwestern Medical Center, and colleagues compared short-term effectiveness and safety outcomes for patients with ischemic stroke treated with intravenous tenecteplase versus alteplase in a comparative effectiveness study using data collected from July 1, 2020, through June 30, 2022. The primary end point was functional independence on discharge.
Data were included for 79,550 patients treated with intravenous thrombolysis, of whom 11.9 and 88.1 percent received tenecteplase and alteplase, respectively. The researchers observed no significant differences between tenecteplase and alteplase in terms of effectiveness or safety outcomes for the overall cohort after adjustment for covariates, including functional independence at discharge, symptomatic intracranial hemorrhage, and in-hospital mortality or hospice discharge. Among patients who were eligible for but did not undergo endovascular thrombectomy, significant improvement with tenecteplase was seen in discharge home, in-hospital mortality, and composite in-hospital mortality or hospice discharge.
"As the adoption of tenecteplase increases across stroke center types, geographic regions, and stroke characteristics, future research will provide additional insight into whether small but clinically important differences in outcomes between tenecteplase and alteplase exist," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Without Biannual Time Shift, Prevalence of Obesity, Stroke May Be Reduced
WEDNESDAY, Sept. 17, 2025 -- The prevalence of obesity and stroke would be reduced with permanent Standard Time (SDT) and Daylight Saving Time (DST) compared with the current...
Stroke Risk May Increase With Hysterectomy, Bilateral Oophorectomy
THURSDAY, Sept. 11, 2025 -- Women who have had a hysterectomy and/or bilateral oophorectomy may have increased stroke risk, according to a study published online Sept. 2 in...
Acute Ischemic Stroke Up in Native Hawaiian, Pacific Islander People
FRIDAY, Sept. 5, 2025 -- The incidence of acute ischemic stroke (AIS) is higher among Native Hawaiian or Pacific Islander (NHOPI) individuals than among other racial and ethnic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.